The Nigerian Medical Association has asked the Federal Government to establish and properly equip more cancer and kidney treatment centres, warning that the shortage of specialist facilities is pushing patients into avoidable suffering and costly trips abroad. Its president, Prof. Afekhide Omoti, said the centres must be matched with skilled staff, steady funding and regular maintenance if they are to make any real difference.
Omoti, a professor of ophthalmology elected to lead the association for the 2026 to 2028 term, argued that buildings and machines alone would not fix the problem. He said Nigeria should concentrate expertise and technology in a few nationally recognised centres of excellence for cancer, cardiac, kidney and transplant care rather than spreading thin resources across many weak facilities.
His call lands against a heavy and rising disease burden. According to the Global Cancer Observatory, Nigeria recorded 127,763 new cancer cases and 79,542 deaths in 2022, with about 269,000 people living with the disease within a five-year window. Breast, prostate and cervical cancers were the most common, together making up roughly half of all new cases.
The kidney picture is just as stark. The Nigerian Association of Nephrology estimates that more than 20 million Nigerians live with some form of kidney disease, and that about 20,000 of them reach end-stage failure every year, needing dialysis or a transplant to survive. Many never get that far, priced out of treatment or too far from a working machine.
The World Health Organisation has estimated that non-communicable diseases such as cancer, kidney failure, diabetes and heart disease accounted for around 27 per cent of all deaths in Nigeria in 2019. Health experts describe a country caught in a double bind, carrying a growing load of these chronic conditions while still fighting infectious diseases.
The financial drain is part of what makes the matter politically sensitive. The Coordinating Minister of Health and Social Welfare, Muhammad Pate, put Nigeria’s annual loss to medical tourism at about two billion dollars in April 2025, money spent largely on treatments, including cancer and kidney care, that are scarce at home. Omoti noted that most patients who travel do so for complex procedures rather than routine care, which is exactly where local capacity is weakest.
Government has taken some steps. President Bola Tinubu approved a subsidy in 2025 that cut the cost of a dialysis session in federal hospitals from about N50,000 to N12,000, and the health ministry has rolled it out across hospitals in the six geopolitical zones. On cancer, the government is building new treatment centres through a partnership between the Federal Ministry of Health and the Nigeria Sovereign Investment Authority, and has introduced a cost-sharing scheme offering up to N400,000 towards radiotherapy for low-income patients.
Access, however, remains thin on the ground. Kidney patients and advocacy groups have complained that some subsidised centres have only one or two working machines for hundreds of people, forcing waits that stretch into weeks. Cancer patients have faced a similar bottleneck for years, with only a handful of radiotherapy centres serving a population of more than 200 million.
Omoti tied the gap to the exodus of medical professionals, the trend widely known as japa. He said Nigeria could build hospitals and buy equipment, but without skilled hands those investments would not deliver, urging competitive pay, better working conditions, more funding for specialist training and incentives for doctors in the diaspora to return or collaborate remotely.
The association’s demand feeds into the National Cancer Control Plan for 2026 to 2030 and a wider push to keep patients and their money within the country. Whether it changes anything will depend less on fresh promises than on sustained funding, working equipment and staff retained long enough to run the centres the country keeps pledging to build.
